Mahyar Kashani, MD

Director of Male Sexual Health

A Patient-Centered Approach

Mahyar Kashani, MD serves as the Director of Male Sexual Health and Assistant Professor of Urology at Mount Sinai South Nassau Hospital. Born and raised on Long Island, Dr. Kashani is deeply committed to providing exceptional, discreet, and results-driven care to his local community.

He specializes in the comprehensive treatment of Men's Sexual Health conditions, including complex cases of Erectile Dysfunction, Peyronie's Disease, and Male Infertility. Dr. Kashani is one of the few urologists in the region with advanced fellowship training specifically in prosthetic urology (Penile Implants).

Beyond sexual medicine, Dr. Kashani provides expert management for general urologic conditions such as kidney stones, BPH, and voiding dysfunction. His philosophy is simple: listen to the patient, understand their goals, and apply the latest evidence-based treatments to restore their quality of life.

Dr. Mahyar Kashani

Education & Training

Fellowship

Male Sexual Health &
Reproductive Medicine

Lenox Hill Hospital, New York City

Residency

Urologic Surgery

SUNY Downstate Health
Sciences Center, Brooklyn

Medical School

Doctor of Medicine (MD)

SUNY Downstate Health
Sciences Center, Brooklyn

Research & Publications

Peer-Reviewed Articles and Contributions

  1. Lembrikova K, Wolff, DT, Kashani M, Barlog J, Blaivas JG, Weiss JP. Construct validation of an automated 24-h bladder diary smartphone app. Continence Reports. Volume 6, 2023. ISSN 2772-9745: https://doi.org/10.1016/j.contre.2023.100032.
  2. Kashani M, Kabarriti A, D'Souza N, Weiss JP. Single system ectopic ureters: Adult presentation of a congenital anomaly. Continence. 2022 March; 1. 100016. 10.1016/j.cont.2022.100016. https://doi.org/10.1016/j.cont.2022.100016.
  3. Huang AJ, Heard JR, Sharma IK, Gold FE, Gdara O, Weinstein C, Kashani M, Winer AG. #UroSoMe: Growth and innovation of the social media landscape of urology residency programs and applicants during the COVID-19 pandemic. Urol Sci 2022 March;33:14-8
  4. Mano R, Duzgol C, Ganat M, Goldman DA, Blum KA, Silagy AW, Walasek A, Sanchez A, DiNatale RG, Marcon J, Kashan M, Becerra MF, Benfante NE, Coleman JA, Kattan MW, Russo P, Akin O, Ostrovnaya I, Hakimi AA. Somatic mutations as preoperative predictors of metastases in patients with localized clear cell renal cell carcinoma - An exploratory analysis. Urol Oncol. 2021 Sep 24:S1078-1439(21)00381-1. doi: 10.1016/j.urolonc.2021.08.018. Epub ahead of print. PMID: 34580025.
  5. Khusid JA, Kashani M, Fink LE, Weinstein CS, Gupta M. The Impact of the COVID-19 Pandemic on Urology Residents: a Narrative Review. Curr Urol Rep. 2021;22(9):45. Published 2021 Aug 24. doi:10.1007/s11934-021-01063-9
  6. Weng S, DiNatale RG, Silagy A, Mano R, Attalla K, Kashani M, Weiss K, Benfante NE, Winer AG, Coleman JA, Reuter VE, Russo P, Reznik E, Tickoo SK, Hakimi AA. The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and Management. Eur Urol. 2021 Apr;79(4):468-477. doi: 10.1016/j.eururo.2020.09.027. Epub 2020 Oct 10. PMID: 33046271; PMCID: PMC8327325.
  7. Silagy A, Zabor E, Mano R, DiNatale R, Marcon J, Kashani M, Blum K, Reznik E, Jaimes E, Coleman J, Ari Hakimi A, Russo P. Predictors of long-term renal function after kidney surgery for patients with preoperative chronic kidney disease. Can Urol Assoc J. 2021 Feb;15(2):E103-E109. doi: 10.5489/cuaj.6485. PMID: 32744993; PMCID: PMC7864699.
  8. Mano R, Duzgol C, Ganat M, Goldman DA, Blum KA, Silagy AW, Walasek A, Sanchez A, DiNatale RG, Marcon J, Kashan M, Becerra MF, Benfante N, Coleman JA, Kattan MW, Russo P, Akin O, Ostrovnaya I, Hakimi AA. Preoperative nomogram predicting 12-year probability of metastatic renal cancer - evaluation in a contemporary cohort. Urol Oncol. 2020 Nov;38(11):853.e1-853.e7. doi: 10.1016/j.urolonc.2020.07.019. Epub 2020 Sep 6. PMID: 32900625; PMCID: PMC7607679.
  9. Khusid JA, Weinstein CS, Becerra AZ, Kashani M, Robins DJ, Fink LE, Smith MT Jr, Weiss JP. Well-being and education of urology residents during the COVID-19 pandemic: Results of an American National Survey. Int J Clin Pract. 2020 Sep;74(9):e13559. doi: 10.1111/ijcp.13559. Epub 2020 Jun 28. PMID: 32460433; PMCID: PMC7283839.
  10. Casuscelli J, Becerra MF, Manley BJ, Zabor EC, Reznik E, Redzematovic A, Arcila ME, Tennenbaum DM, Ghanaat M, Kashan M, Stief CG, Carlo M, Voss MH, Feldman DR, Motzer RJ, Chen Y, Reuter VE, Coleman JA, Russo P, Hsieh JJ, Hakimi AA. Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma. Eur Urol Focus. 2019 Jul;5(4):642-649. doi: 10.1016/j.euf.2017.09.008. Epub 2017 Sep 24. PMID: 28951115; PMCID: PMC5984188.
  11. Manley BJ, Reznik E, Ghanaat M, Kashan M, Becerra MF, Casuscelli J, Tennenbaum D, Redzematovic A, Carlo MI, Sato Y, Arcila M, Voss MH, Feldman DR, Motzer RJ, Russo P, Coleman J, Hsieh JJ, Hakimi AA. Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations. Urol Oncol. 2019 Jan;37(1):12-17. doi: 10.1016/j.urolonc.2017.10.012. Epub 2017 Nov 11. PMID: 29132830; PMCID: PMC5984192.
  12. Ghanaat M, Winer AG, Sjoberg DD, Poon BY, Kashan M, Tin AL, Sfakianos JP, Cha EK, Donahue TF, Dalbagni G, Herr HW, Bochner BH, Vickers AJ, Donat SM. Comparison of Postradical Cystectomy Ileus Rates Using GIA-80 Versus GIA-60 Intestinal Stapler Device. Urology. 2018 Dec;122:121-126. doi: 10.1016/j.urology.2018.09.010. Epub 2018 Sep 20. PMID: 30244117; PMCID: PMC6526537.
  13. Becerra MF, Reznik E, Redzematovic A, Tennenbaum DM, Kashan M, Ghanaat M, Casuscelli J, Manley B, Jonsson P, DiNatale RG, Blum KA, Durack JC, Solomon SB, Arcila ME, Bourque C, Socci N, Carlo MI, Lee CH, Voss MH, Feldman DR, Motzer RJ, Coleman JA, Russo P, Cheng EH, Hakimi AA, Hsieh JJ. Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma. Eur Urol Focus. 2018 Dec;4(6):986-994. doi: 10.1016/j.euf.2017.09.016. Epub 2017 Oct 20. PMID: 29066084; PMCID: PMC5910293.
  14. Gatto F, Blum KA, Hosseini SS, Ghanaat M, Kashan M, Maccari F, Galeotti F, Hsieh JJ, Volpi N, Hakimi AA, Nielsen J. Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma. Eur Urol Oncol. 2018 Oct;1(5):364-377. doi: 10.1016/j.euo.2018.04.015. Epub 2018 Jun 13. PMID: 31158075; PMCID: PMC8253162.
  15. Kashan M, Ghanaat M, Hötker AM, Duzgol C, Sanchez A, DiNatale RG, Blum KA, Becerra MF, Manley BJ, Casuscelli J, Chiok M, Coleman JA, Russo P, Tickoo SK, Akin O, Hakimi AA. Cystic Renal Cell Carcinoma: A Report on Outcomes of Surgery and Active Surveillance in Patients Retrospectively Identified on Pretreatment Imaging. J Urol. 2018 Aug;200(2):275-282. doi: 10.1016/j.juro.2018.02.3087. Epub 2018 Mar 1. PMID: 29496470; PMCID: PMC6050111.
  16. Mendonca SJ, Sanchez A, Blum KA, Ghanaat M, Kashan MY, Benfante N, Russo P, Coleman JA, Crago AM, Hakimi AA. The association of renal cell carcinoma with gastrointestinal stromal tumors. J Surg Oncol. 2018 Jun;117(8):1716-1720. doi: 10.1002/jso.25080. Epub 2018 Jun 7. PMID: 29878354; PMCID: PMC6135662.
  17. Thorner DA, Blaivas JG, Tsui JF, Kashan MY, Weinberger JM, Weiss JP. Outcomes of reduction cystoplasty in men with impaired detrusor contractility. Urology. 2014 Apr;83(4):882-6. doi: 10.1016/j.urology.2013.10.068. Epub 2014 Feb 16. PMID: 24548706.
  18. Hillelsohn JH, Rais-Bahrami S, Bagadiya N, Kashan M, Weiss GH. Use of desipramine for the treatment of overactive bladder refractory to antimuscarinic therapy. Urol J. 2014 Jan 4;10(4):1114-8. PMID: 24469659.
  19. Tsui JF, Weinberger JM, Kashan M, Weiss JP, Robinson BD, Blaivas JG. Bladder lipoma. J Urol. 2013 Oct;190(4):1387-8. doi: 10.1016/j.juro.2013.07.021. Epub 2013 Jul 18. PMID: 23871930.
  20. Hillelsohn JH, Friedlander JI, Bagadiya N, Okhunov Z, Kashan M, Schwartzur M, Kavoussi L. Masked pneumothorax: risk of valveless trocar systems. J Urol. 2013 Mar;189(3):955-9. doi: 10.1016/j.juro.2012.08.244. Epub 2012 Sep 24. PMID: 23017523.
  21. Hillelsohn JH, Duty B, Blute ML Jr, Okhunov Z, Kashan M, Moldwin R, Ashley RN. Variability of transrectal ultrasound-guided prostate biopsy prophylactic measures. Can J Urol. 2012 Dec;19(6):6573-7. PMID: 23228295.
  22. Hillelsohn JH, Rais-Bahrami S, Friedlander JI, Okhunov Z, Kashan M, Rosen L, Moldwin RM. Fulguration for Hunner ulcers: long-term clinical outcomes. J Urol. 2012 Dec;188(6):2238-41. doi: 10.1016/j.juro.2012.08.013. Epub 2012 Oct 22. PMID: 23083651.

Media & Patient Education

Video Library